Question 1

Does Hotchkis & Wiley Capital Management own ELV stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Hotchkis & Wiley Capital Management holds 2,016,200 shares of ELV (Elevance Health), worth $779.7M.

Question 2

How many shares of ELV does Hotchkis & Wiley Capital Management own?

Accepted Answer

As of its Q2 2026 13F, Hotchkis & Wiley Capital Management holds 2,016,200 shares of ELV (Elevance Health).

Question 3

What is Hotchkis & Wiley Capital Management's ELV position worth?

Accepted Answer

As of its Q2 2026 13F, Hotchkis & Wiley Capital Management's ELV position is worth $779.7M.

Question 4

Is Hotchkis & Wiley Capital Management buying or selling ELV?

Accepted Answer

In Q2 2026, Hotchkis & Wiley Capital Management reduced its ELV position by 175,363 shares (-8.0%).

Question 5

When did Hotchkis & Wiley Capital Management first buy ELV?

Accepted Answer

Hotchkis & Wiley Capital Management already held ELV in its Q4 2018 13F, the earliest on record, and has listed it in 31 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	2M	-8.0%	$779.7M	2.3%	$385.05	0
2026-Q1	Increased	2.2M	+6.8%	$641.6M	2.0%	$290.30	53
2025-Q4	Increased	2.1M	+0.3%	$719M	2.1%	$345.49	54
2025-Q3	Increased	2M	+44.2%	$660.9M	2.0%	$316.82	73
2025-Q2	Decreased	1.4M	-20.2%	$551.7M	1.8%	$379.31	0
2025-Q1	Increased	1.8M	+0.1%	$773.2M	2.6%	$422.30	54
2024-Q4	Increased	1.8M	+42.9%	$655M	2.2%	$356.67	73
2024-Q3	Decreased	1.2M	-5.4%	$646.4M	2.1%	$500.71	0
2024-Q2	Decreased	1.3M	-12.5%	$711.8M	2.5%	$520.20	0
2024-Q1	Decreased	1.5M	-7.0%	$778.1M	2.6%	$496.30	0
2023-Q4	Decreased	1.6M	-6.3%	$761.3M	2.7%	$449.88	0
2023-Q3	Increased	1.7M	+8.4%	$750.1M	2.8%	$414.13	59
2023-Q2	Increased	1.6M	+23.1%	$706.1M	2.6%	$421.16	66
2023-Q1	Increased	1.3M	+61.6%	$593.5M	2.3%	$434.47	78
2022-Q4	Decreased	798,555	-25.9%	$409.6M	1.6%	$483.17	0
2022-Q3	Decreased	1.1M	-13.2%	$489.8M	2.1%	$426.81	0
2022-Q2	Decreased	1.2M	-27.8%	$599.5M	2.4%	$452.24	0
2022-Q1	Decreased	1.7M	-17.9%	$845.1M	2.7%	$459.15	0
2021-Q4	Decreased	2.1M	-12.0%	$971.9M	3.1%	$432.06	0
2021-Q3	Decreased	2.4M	-2.8%	$888.5M	2.8%	$346.52	0
2021-Q2	Decreased	2.5M	-6.0%	$936.3M	2.9%	$353.80	0
2021-Q1	Increased	2.6M	+13.0%	$936.4M	2.9%	$331.67	62
2020-Q4	Increased	2.3M	+12.3%	$741.2M	2.6%	$295.70	61
2020-Q3	Increased	2.1M	+23.3%	$552.1M	2.5%	$246.62	65
2020-Q2	Increased	1.7M	+0.3%	$438.3M	2.0%	$240.61	54
2020-Q1	Increased	1.7M	+31.4%	$377.1M	2.1%	$207.07	68
2019-Q4	Increased	1.3M	+8.3%	$381.8M	1.3%	$274.45	53
2019-Q3	Increased	1.2M	+36.1%	$280.3M	1.1%	$217.56	63
2019-Q2	Increased	857,911	+51.8%	$242.1M	0.9%	$254.90	60
2019-Q1	Decreased	565,301	-3.2%	$162.2M	0.6%	$258.46	0
2018-Q4	First report	583,770	-	$153.3M	0.7%	$235.91	0

ELV31 quarters

ELV
31 quarters